Antigua and Barbuda has initiated a landmark legislative review process to comprehensively update its pharmaceutical regulations, marking a significant step toward modernizing the nation’s healthcare governance framework. The two-day consultation forum, which commenced Monday at Parliament, brings together diverse stakeholders to examine the proposed Pharmacy Bill and Regulations 2026.
The collaborative initiative, jointly organized by the Antigua and Barbuda Pharmacy Council and the Chief Parliamentary Counsel’s Office under the Ministry of Legal Affairs, represents the most substantial overhaul of pharmaceutical legislation in recent history. Preliminary documents indicate the proposed legislation will address multiple critical areas including pharmacy practice standards, controlled substance distribution protocols, and enhanced regulatory mechanisms for pharmaceutical professionals and establishments.
Monday’s proceedings featured specialized sessions tailored to different industry segments. Morning discussions engaged practicing pharmacists, while afternoon deliberations included wholesalers, pharmacy proprietors, and their professional staff. The opening ceremony witnessed addresses from Health Minister Sir Molwyn Joseph and Minister of State Michael Joseph, underscoring the government’s commitment to regulatory modernization.
Tuesday’s agenda expands participation to include broader societal input. Morning sessions will incorporate perspectives from general citizens and key regulatory agencies including Customs, Police, the Office of National Drug Control Policy, the Pesticide Board, and the Forensic Laboratory. Afternoon consultations will specifically seek expertise from medical doctors, veterinary professionals, and dental practitioners, ensuring comprehensive multidisciplinary input before final legislative formulation.